News Conference News PCR London Valves 2024 Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia Michael O'Riordan November 26, 2024
News Conference News TCT 2023 Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots Caitlin E. Cox November 03, 2023
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Conference News TCT 2022 TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US Caitlin E. Cox September 16, 2022
News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Conference News AHA 2019 TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences Yael L. Maxwell November 18, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News SCAI 2019 TAVR Operators: Can One Do It All or Are Two Still Justified? Yael L. Maxwell June 04, 2019
News Conference News STS 2019 TAVR More Prevalent in Highly Competitive Hospital Markets Yael L. Maxwell February 04, 2019
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016